Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Incyte
Biotech
Incyte pays Genesis $80M to expand AI-fueled drug discovery pact
Incyte will use its partner’s platform across a broader range of targets, continuing the biotech’s rapid embrace of AI for drug discovery.
Nick Paul Taylor
May 20, 2026 10:22am
Incyte inks deal with Edison to train AI through drug discovery
May 19, 2026 10:30am
Incyte’s vitiligo bet scores ph. 3 wins but can’t shake off Rinvoq
Apr 28, 2026 9:52am
Tang takes over Aurinia after FDA brouhaha—Chutes & Ladders
Mar 27, 2026 11:05am
Midsize biotechs form coalition to fight against MFN policy
Feb 25, 2026 1:05pm
Prelude loses CMO, pauses SMARCA2 degraders, scores Incyte cash
Nov 4, 2025 9:40am
